GLOBAL MEDICAL REIT INC (GMRE) Fundamental Analysis & Valuation

NYSE:GMRE • US37954A3032

Current stock price

35.98 USD
-0.01 (-0.03%)
At close:
35.98 USD
0 (0%)
After Hours:

This GMRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. GMRE Profitability Analysis

1.1 Basic Checks

  • In the past year GMRE was profitable.
  • In the past year GMRE had a positive cash flow from operations.
  • Of the past 5 years GMRE 4 years were profitable.
  • GMRE had a positive operating cash flow in 4 of the past 5 years.
GMRE Yearly Net Income VS EBIT VS OCF VS FCFGMRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

  • GMRE has a Return On Assets of -0.26%. This is in the lower half of the industry: GMRE underperforms 62.60% of its industry peers.
  • With a Return On Equity value of -0.69%, GMRE is not doing good in the industry: 62.60% of the companies in the same industry are doing better.
  • GMRE's Return On Invested Capital of 2.18% is on the low side compared to the rest of the industry. GMRE is outperformed by 60.98% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for GMRE is in line with the industry average of 3.13%.
Industry RankSector Rank
ROA -0.26%
ROE -0.69%
ROIC 2.18%
ROA(3y)0.73%
ROA(5y)0.48%
ROE(3y)1.6%
ROE(5y)0.99%
ROIC(3y)2.29%
ROIC(5y)2.1%
GMRE Yearly ROA, ROE, ROICGMRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

  • In the last couple of years the Profit Margin of GMRE has declined.
  • With a Operating Margin value of 23.29%, GMRE perfoms like the industry average, outperforming 52.85% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GMRE has declined.
  • The Profit Margin and Gross Margin are not available for GMRE so they could not be analyzed.
Industry RankSector Rank
OM 23.29%
PM (TTM) N/A
GM N/A
OM growth 3Y-9.47%
OM growth 5Y-9.28%
PM growth 3Y-61.43%
PM growth 5Y-34.4%
GM growth 3YN/A
GM growth 5YN/A
GMRE Yearly Profit, Operating, Gross MarginsGMRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. GMRE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GMRE is destroying value.
  • GMRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GMRE Yearly Shares OutstandingGMRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GMRE Yearly Total Debt VS Total AssetsGMRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • GMRE has an Altman-Z score of 0.17. This is a bad value and indicates that GMRE is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.17, GMRE is doing worse than 68.29% of the companies in the same industry.
  • GMRE has a Debt/Equity ratio of 1.46. This is a high value indicating a heavy dependency on external financing.
  • GMRE has a Debt to Equity ratio (1.46) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACC0.35
WACC6.16%
GMRE Yearly LT Debt VS Equity VS FCFGMRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 0.33 indicates that GMRE may have some problems paying its short term obligations.
  • The Current ratio of GMRE (0.33) is worse than 86.18% of its industry peers.
  • GMRE has a Quick Ratio of 0.33. This is a bad value and indicates that GMRE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of GMRE (0.33) is worse than 82.93% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
GMRE Yearly Current Assets VS Current LiabilitesGMRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. GMRE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 445.00% over the past year.
  • The Earnings Per Share has been growing by 19.36% on average over the past years. This is quite good.
EPS 1Y (TTM)445%
EPS 3Y2.91%
EPS 5Y19.36%
EPS Q2Q%288%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.2%

3.2 Future

  • The Earnings Per Share is expected to decrease by -56.17% on average over the next years. This is quite bad
  • Based on estimates for the next years, GMRE will show a small growth in Revenue. The Revenue will grow by 2.68% on average per year.
EPS Next Y-78.48%
EPS Next 2Y-38.82%
EPS Next 3Y-56.17%
EPS Next 5YN/A
Revenue Next Year3.18%
Revenue Next 2Y3.38%
Revenue Next 3Y2.68%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GMRE Yearly Revenue VS EstimatesGMRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
GMRE Yearly EPS VS EstimatesGMRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

1

4. GMRE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 33.01, the valuation of GMRE can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as GMRE.
  • The average S&P500 Price/Earnings ratio is at 27.87. GMRE is around the same levels.
  • GMRE is valuated quite expensively with a Price/Forward Earnings ratio of 153.37.
  • GMRE's Price/Forward Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.51, GMRE is valued quite expensively.
Industry RankSector Rank
PE 33.01
Fwd PE 153.37
GMRE Price Earnings VS Forward Price EarningsGMRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GMRE is valued a bit cheaper than 68.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.1
GMRE Per share dataGMRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • A cheap valuation may be justified as GMRE's earnings are expected to decrease with -56.17% in the coming years.
PEG (NY)N/A
PEG (5Y)1.71
EPS Next 2Y-38.82%
EPS Next 3Y-56.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. GMRE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.61%, GMRE is a good candidate for dividend investing.
  • GMRE's Dividend Yield is a higher than the industry average which is at 7.42.
  • GMRE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 7.61%

5.2 History

  • The dividend of GMRE is nicely growing with an annual growth rate of 37.64%!
  • GMRE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of GMRE decreased in the last 3 years.
Dividend Growth(5Y)37.64%
Div Incr Years0
Div Non Decr Years2
GMRE Yearly Dividends per shareGMRE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • The earnings of GMRE are negative and hence is the payout ratio. GMRE will probably not be able to sustain this dividend level.
DP-1886.35%
EPS Next 2Y-38.82%
EPS Next 3Y-56.17%
GMRE Yearly Income VS Free CF VS DividendGMRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

GMRE Fundamentals: All Metrics, Ratios and Statistics

GLOBAL MEDICAL REIT INC

NYSE:GMRE (2/20/2026, 8:04:00 PM)

After market: 35.98 0 (0%)

35.98

-0.01 (-0.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners71.79%
Inst Owner Change0%
Ins Owners0.51%
Ins Owner Change0.3%
Market Cap482.49M
Revenue(TTM)N/A
Net Income(TTM)-3.33M
Analysts78.67
Price Target41.67 (15.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.61%
Yearly Dividend4.96
Dividend Growth(5Y)37.64%
DP-1886.35%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-95.33%
Min EPS beat(2)-132.68%
Max EPS beat(2)-57.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.45%
Min Revenue beat(2)-4.34%
Max Revenue beat(2)5.24%
Revenue beat(4)1
Avg Revenue beat(4)-0.91%
Min Revenue beat(4)-4.34%
Max Revenue beat(4)5.24%
Revenue beat(8)2
Avg Revenue beat(8)-2.13%
Revenue beat(12)2
Avg Revenue beat(12)-2.18%
Revenue beat(16)3
Avg Revenue beat(16)-1.81%
PT rev (1m)1.51%
PT rev (3m)0.73%
EPS NQ rev (1m)95.02%
EPS NQ rev (3m)8.33%
EPS NY rev (1m)0%
EPS NY rev (3m)20.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE 33.01
Fwd PE 153.37
P/S 3.33
P/FCF N/A
P/OCF 6.7
P/B 0.99
P/tB 1.13
EV/EBITDA 13.1
EPS(TTM)1.09
EY3.03%
EPS(NY)0.23
Fwd EY0.65%
FCF(TTM)-4.35
FCFYN/A
OCF(TTM)5.37
OCFY14.92%
SpS10.81
BVpS36.19
TBVpS31.98
PEG (NY)N/A
PEG (5Y)1.71
Graham Number29.7914 (-17.2%)
Profitability
Industry RankSector Rank
ROA -0.26%
ROE -0.69%
ROCE 2.75%
ROIC 2.18%
ROICexc 2.19%
ROICexgc 2.32%
OM 23.29%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.73%
ROA(5y)0.48%
ROE(3y)1.6%
ROE(5y)0.99%
ROIC(3y)2.29%
ROIC(5y)2.1%
ROICexc(3y)2.3%
ROICexc(5y)2.11%
ROICexgc(3y)2.52%
ROICexgc(5y)2.3%
ROCE(3y)2.9%
ROCE(5y)2.66%
ROICexgc growth 3Y-3.14%
ROICexgc growth 5Y-2.71%
ROICexc growth 3Y-3.1%
ROICexc growth 5Y-2.82%
OM growth 3Y-9.47%
OM growth 5Y-9.28%
PM growth 3Y-61.43%
PM growth 5Y-34.4%
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF N/A
Debt/EBITDA 7.84
Cap/Depr 229.77%
Cap/Sales 89.9%
Interest Coverage 1.16
Cash Conversion 79.54%
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z 0.17
F-Score3
WACC6.16%
ROIC/WACC0.35
Cap/Depr(3y)155.62%
Cap/Depr(5y)302.85%
Cap/Sales(3y)63.21%
Cap/Sales(5y)120.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)445%
EPS 3Y2.91%
EPS 5Y19.36%
EPS Q2Q%288%
EPS Next Y-78.48%
EPS Next 2Y-38.82%
EPS Next 3Y-56.17%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%9.2%
Revenue Next Year3.18%
Revenue Next 2Y3.38%
Revenue Next 3Y2.68%
Revenue Next 5YN/A
EBIT growth 1Y-3.06%
EBIT growth 3Y-3.87%
EBIT growth 5Y3.82%
EBIT Next Year173.9%
EBIT Next 3Y43.15%
EBIT Next 5Y31.78%
FCF growth 1Y-196.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.88%
OCF growth 3Y0.52%
OCF growth 5Y13.97%

GLOBAL MEDICAL REIT INC / GMRE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GLOBAL MEDICAL REIT INC (GMRE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GMRE.


What is the valuation status of GLOBAL MEDICAL REIT INC (GMRE) stock?

ChartMill assigns a valuation rating of 1 / 10 to GLOBAL MEDICAL REIT INC (GMRE). This can be considered as Overvalued.


Can you provide the profitability details for GLOBAL MEDICAL REIT INC?

GLOBAL MEDICAL REIT INC (GMRE) has a profitability rating of 2 / 10.


How financially healthy is GLOBAL MEDICAL REIT INC?

The financial health rating of GLOBAL MEDICAL REIT INC (GMRE) is 1 / 10.


Can you provide the expected EPS growth for GMRE stock?

The Earnings per Share (EPS) of GLOBAL MEDICAL REIT INC (GMRE) is expected to decline by -78.48% in the next year.